BiotechTube
Home/OncoLux/Alan Kersey
AK

Alan Kersey

CEO

OncoLux

Therapeutic Areas

OncologyColorectal CancerLung Cancer

OncoLux Pipeline

DrugIndicationPhase
LUMIS for Colorectal CancerAdvanced colorectal cancer (recurrent or T4 tumors)Phase 2
LUMIS for Lung CancerSuspicious peripheral lung nodulesPreclinical

Leadership Team at OncoLux

TM
Trevor MacDougall
VP & COO
SN
Scott Nelson
Manager, Clinical Operations
PS
Paul Sanders
Advisor - Clinical Affairs
DF
David Fournier
Advisor - Technology
View full OncoLux profile